Johnson & Johnson (JNJ.US) has agreed to pay more than $8.2 billion to settle lawsuits over its baby powder's cancer risk.

Written byAInvest Visual
Friday, Sep 20, 2024 9:40 am ET1min read
JNJ--

Johnson & Johnson (JNJ.US) has raised the amount it is willing to pay to settle thousands of lawsuits alleging its baby powder caused cancer to over $8.2 billion from its previous offer of $6.5 billion, according to people familiar with the matter. The decision to increase the settlement amount will bring the total amount Johnson & Johnson has agreed to pay or has already paid to resolve lawsuits related to its baby powder to over $13.4 billion. The new terms also allow claimants to receive higher compensation and about $650 million in legal fees, the people said. Negotiations are ongoing.

Turning market noise into visual signal.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet